Raymond James Financial
UTMD icon

Raymond James Financial’s Utah Medical Products UTMD Stock Holding History

Raymond James Financial’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Sell
5,166
-35
-0.7% -$2.33K ﹤0.01% 4720
2026
Q1 		$322K Buy
+5,201
New +$328K ﹤0.01% 4620

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raymond James Financial's UTMD Position: Q2 2026 in Review

Raymond James Financial reduced its Utah Medical Products (UTMD) stake by 0.67% in Q2 2026, selling an estimated $2.33K and leaving 5,166 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #4720.

Raymond James Financial first reported a position in UTMD in Q1 2026 and has held it in 2 quarters since. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Raymond James Financial held 5,166 shares of Utah Medical Products worth $356K as of Q2 2026.
  • Raymond James Financial sold 35 Utah Medical Products shares in Q2 2026, an estimated $2.33K.
  • Utah Medical Products made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4720 holding.
  • Raymond James Financial first reported a position in Utah Medical Products in Q1 2026 and has held it in 2 quarters since.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.